上海荣泰健康科技股份有限公司关于使用闲置募集资金进行现金管理赎回的进展公告

Group 1 - The company has approved the use of idle funds from convertible bonds for cash management, with a maximum amount of RMB 450 million allocated for investment in low-risk financial products or structured deposits [1] - The board meetings held on April 23, 2025, and the annual shareholders' meeting on May 14, 2025, confirmed the decision to utilize these funds within a 12-month authorization period [1] - The company has successfully redeemed a large deposit of RMB 50 million from Hangzhou Bank, with a total return of RMB 91.70 thousand received [2][3] Group 2 - As of the announcement date, the company has no overdue funds from cash management activities, with an unexpired balance of RMB 398 million remaining [2]